CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
June 06, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
May 28, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
May 10, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 10, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 07:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024
May 06, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
April 19, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
April 15, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
April 11, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
April 08, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
March 27, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...